Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website


Fresenius reported EUR19.1B in Current Assets for its fiscal quarter ending in March of 2023.

Current Assets Change
Akzo Nobel AKZA:NA EUR 6.15B 97M
Alcon AG ALC:SW USD 5.33B 138M
AstraZeneca AZN:LN USD 22.27B 327M
BASF BAS:GR EUR 39.14B 1.72B
Bayer BAYN:GR EUR 39.62B 1.86B
DaVita Healthcare Partners DVA:US USD 3.04B 115.55M
Demant A/s WDH:DC DKK 10.02B 96M
E.ON EOAN:GR EUR 45.74B 6.5B
Essilor EI:FP EUR 8.64B 2B
Fresenius FRE:GR EUR 19.1B 823M
Getinge GETIB:SS SEK 17.91B 1.2B
Givaudan GIVN:VX CHF 3.71B 235M
GlaxoSmithKline GSK:LN GBP 19.72B 1.05B
GN Store Nord GN:DC DKK 8.73B 637M
Hikma Pharmaceutical HIK:LN USD 2B 145M
Lonza Group LONN:SW CHF 5.72B 13M
Merck MRK:GR EUR 12.95B 750M
Novartis NOVN:VX USD 32.11B 4.8B
Roche Holding ROG:VX CHF 33.82B 3.5B
RWE RWE:GR EUR 70.12B 26.14B
Smith & Nephew PLC SN/:LN USD 3.86B 97M